KALARIS THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
KALARIS THERAPEUTICS, INC. (KLRS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $5.93 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2025-03-07
- KALARIS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $5.93M, a 15.22% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $6.99M, a 26.21% increase from fiscal 2021.
- KALARIS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $5.54M, a 354.10% increase from fiscal 2020.
- KALARIS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2020 was $1.22M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|
| 2023-12-31 | $5.93M 10-K · filed 2025-03-07 |
| 2022-12-31 | $6.99M 10-K · filed 2024-03-15 |
| 2021-12-31 | $5.54M 10-K · filed 2023-02-15 |
| 2020-12-31 | $1.22M 10-K · filed 2022-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |